rs73139245

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001378609.3(OTOGL):​c.5923T>C​(p.Leu1975Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0054 in 1,593,886 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0052 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 28 hom. )

Consequence

OTOGL
NM_001378609.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0700

Publications

1 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-80356818-T-C is Benign according to our data. Variant chr12-80356818-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226961.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.07 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00522 (794/152224) while in subpopulation NFE AF = 0.00766 (521/68010). AF 95% confidence interval is 0.00712. There are 5 homozygotes in GnomAd4. There are 428 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.5923T>C p.Leu1975Leu synonymous_variant Exon 49 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.5923T>C p.Leu1975Leu synonymous_variant Exon 49 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5

Frequencies

GnomAD3 genomes
AF:
0.00523
AC:
795
AN:
152106
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0199
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00767
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00566
AC:
1318
AN:
232748
AF XY:
0.00576
show subpopulations
Gnomad AFR exome
AF:
0.000837
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00126
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0169
Gnomad NFE exome
AF:
0.00824
Gnomad OTH exome
AF:
0.00537
GnomAD4 exome
AF:
0.00542
AC:
7814
AN:
1441662
Hom.:
28
Cov.:
29
AF XY:
0.00544
AC XY:
3896
AN XY:
716728
show subpopulations
African (AFR)
AF:
0.000768
AC:
25
AN:
32552
American (AMR)
AF:
0.00113
AC:
47
AN:
41574
Ashkenazi Jewish (ASJ)
AF:
0.00106
AC:
27
AN:
25542
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38820
South Asian (SAS)
AF:
0.0000366
AC:
3
AN:
82008
European-Finnish (FIN)
AF:
0.0144
AC:
766
AN:
53012
Middle Eastern (MID)
AF:
0.000705
AC:
4
AN:
5674
European-Non Finnish (NFE)
AF:
0.00608
AC:
6701
AN:
1103016
Other (OTH)
AF:
0.00405
AC:
241
AN:
59464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
351
701
1052
1402
1753
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00522
AC:
794
AN:
152224
Hom.:
5
Cov.:
32
AF XY:
0.00575
AC XY:
428
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41552
American (AMR)
AF:
0.00170
AC:
26
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.0199
AC:
211
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00766
AC:
521
AN:
68010
Other (OTH)
AF:
0.00237
AC:
5
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00556
Hom.:
2
Bravo
AF:
0.00345
Asia WGS
AF:
0.00115
AC:
4
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OTOGL: BP4, BP7, BS2 -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1966Leu in exon 48 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.5% (44/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs73139245). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.1
DANN
Benign
0.68
PhyloP100
0.070
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73139245; hg19: chr12-80750598; COSMIC: COSV54024860; COSMIC: COSV54024860; API